Shandong Xinhua Pharmaceutical Company Limited (HKG:0719)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
6.41
-0.13 (-1.99%)
May 12, 2026, 4:08 PM HKT

HKG:0719 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Cash & Equivalents
1,2771,3971,245918.331,159744.66
Cash & Short-Term Investments
1,2771,3971,245918.331,159744.66
Cash Growth
-2.15%12.18%35.57%-20.75%55.61%-12.98%
Accounts Receivable
1,4231,2091,120949.16970.63870.46
Other Receivables
11.2939.59.3412.6517.42
Receivables
1,4341,2121,129958.5983.28887.87
Inventory
1,2161,3181,2731,3131,2121,028
Prepaid Expenses
-0.020.033.41--
Other Current Assets
125.25106.7979.78121.1102.9593.88
Total Current Assets
4,0524,0333,7273,3143,4572,754
Property, Plant & Equipment
4,0634,1524,2964,0614,0003,766
Long-Term Investments
312.45338.27306.42241.37239.18260.2
Other Intangible Assets
557.54577.4565.04494.94474.11466.45
Long-Term Deferred Tax Assets
16.8421.1924.9223.4815.6215.17
Long-Term Deferred Charges
20.0215.769.9914.468.6110.54
Other Long-Term Assets
46.8247.8290.75136.7769.8559.99
Total Assets
9,0699,1869,0208,2868,2657,332
Accounts Payable
1,2301,3111,1591,1781,0901,066
Accrued Expenses
47.3576.7888.86203.11159.43122.35
Short-Term Debt
454.76433.64580.16283.96118.02269.46
Current Portion of Long-Term Debt
23.25351.21312.26271.97714.77421.03
Current Portion of Leases
-0.941.41.782.692.8
Current Income Taxes Payable
37.811.556.695.037.9912.2
Current Unearned Revenue
85.98149.396.84149.14593.26100.4
Other Current Liabilities
417.53476.66550.72393.16472.23507.26
Total Current Liabilities
2,2972,8112,7962,4863,1582,502
Long-Term Debt
942.32695.32771.54799.4545.66946.2
Long-Term Leases
0.730.741.111.582.726.77
Long-Term Unearned Revenue
65.0568.9783.25100.67118.37133.97
Long-Term Deferred Tax Liabilities
140.14125.67122.5399.2166.4465.61
Other Long-Term Liabilities
28.0628.0628.0623.5623.5626.46
Total Liabilities
3,4733,7303,8023,5103,9153,681
Common Stock
696.68689.78682.41674.68669.63627.37
Additional Paid-In Capital
1,2751,2051,1451,055998.14677.94
Retained Earnings
3,1903,1062,9892,7062,3452,034
Comprehensive Income & Other
187.63208.12175.86117.01113.68128.37
Total Common Equity
5,3505,2094,9924,5534,1263,468
Minority Interest
246.07246.97225.91222.65223.29183.2
Shareholders' Equity
5,5965,4565,2184,7764,3503,651
Total Liabilities & Equity
9,0699,1869,0208,2868,2657,332
Total Debt
1,4211,4821,6661,3591,3841,646
Net Cash (Debt)
-144.48-85.2-421.45-440.36-225.11-901.58
Net Cash Per Share
-0.21-0.12-0.61-0.64-0.34-1.44
Filing Date Shares Outstanding
699.19696.68689.78682.41669.63627.37
Total Common Shares Outstanding
699.19689.78682.41674.68669.63627.37
Working Capital
1,7551,222931.23828.33298.47252.08
Book Value Per Share
7.657.557.316.756.165.53
Tangible Book Value
4,7924,6314,4274,0583,6523,001
Tangible Book Value Per Share
6.856.716.496.015.454.78
Buildings
-2,6422,4112,2712,2442,078
Machinery
-5,6475,1284,7034,4684,011
Construction In Progress
-366.17781.1730.55545.89562.96
Source: S&P Global Market Intelligence. Standard template. Financial Sources.